UK trial aims to find treatments that can slow or reverse motor neurone disease

pharmafile | January 17, 2020 | News story | Medical Communications MND, Motor Neurone, clinical trial, motor neurone disease, trial 

A UK wide trial called MND-SMART has invited hundreds of people with motor neurone disease (MND) to participate. It will analyse treatments that can slow, stop or reverse disease progression.

The trial has been developed by people with MND and clinical trial experts from across the UK. This includes specialists from the Euan MacDonald Centre for MND Research at the University of Edinburgh, University College London and the University of Warwick.

MND-SMART will include as many people with the condition as possible regardless of how disease or current treatments affect them.

Initially, researchers will test drugs that are already licensed for use in other conditions to check whether they offer any benefit for people with MND. The trial is designed to be adaptive so the researchers can modify their approach according to emerging results. New drugs can be added and dropped based on how effective they are.

Euan MacDonald, who has MND and is the co-founder of the Euan MacDonald Centre for MND Research, said: “This is the result of 10 years of hard work and collaboration and we are thankful to those involved. Clinical trials like this provide hope that people around the world with MND will one day have access to safe and effective treatments.”

Conor Kavanagh

 

Related Content

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

Sanofi has announced positive results from its phase 3 LUNA 3 study, which assessed rilzabrutinib …

GSK shares results from phase 3 trial for gonorrhoea treatment

GSK has announced positive results from its phase 3 EAGLE-1 trial for gepotidacin, a potential …

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

Eli Lilly has announced positive topline results from its SURMOUNT-OSA phase 3 trials which demonstrated …

Latest content